Fulgent Genetics Is Fundamentally Sound

  • Fulgent’s growth is going to come down this year, according to guidance which was issued just before the coronavirus hit the US in earnest.
  • From competitors with more recent updates, the picture doesn’t seem to be too alarming, at least not yet.
  • Fulgent remains a solid growth company, and investors can nibble at the shares on one of the downswings.
  • The big unknown is of course by how much the coronavirus pandemic will reduce growth, as that situation can get worse.

Source: Fulgent Genetics Is Fundamentally Sound (NASDAQ:FLGT) | Seeking Alpha